Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Cited In for PubMed (Select 18459106)

1.

Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.

Kachakova D, Mitkova A, Popov E, Popov I, Vlahova A, Dikov T, Christova S, Mitev V, Slavov C, Kaneva R.

DNA Cell Biol. 2015 Mar;34(3):189-200. doi: 10.1089/dna.2014.2663. Epub 2014 Dec 18.

2.

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy.

Mortensen MM, Høyer S, Orntoft TF, Sørensen KD, Dyrskjøt L, Borre M.

BMC Cancer. 2014 Nov 21;14:859. doi: 10.1186/1471-2407-14-859.

3.

Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.

Melbø-Jørgensen C, Ness N, Andersen S, Valkov A, Dønnem T, Al-Saad S, Kiselev Y, Berg T, Nordby Y, Bremnes RM, Busund LT, Richardsen E.

PLoS One. 2014 Nov 17;9(11):e113039. doi: 10.1371/journal.pone.0113039. eCollection 2014.

4.

Epithelial and stromal expression of miRNAs during prostate cancer progression.

Ren Q, Liang J, Wei J, Basturk O, Wang J, Daniels G, Gellert LL, Li Y, Shen Y, Osman I, Zhao J, Melamed J, Lee P.

Am J Transl Res. 2014 Jul 18;6(4):329-39. eCollection 2014.

5.

MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.

Ke TW, Hsu HL, Wu YH, Chen WT, Cheng YW, Cheng CW.

Dis Markers. 2014;2014:617150. doi: 10.1155/2014/617150. Epub 2014 Apr 10.

6.

Understanding cooperativity of microRNAs via microRNA association networks.

Na YJ, Kim JH.

BMC Genomics. 2013;14 Suppl 5:S17. doi: 10.1186/1471-2164-14-S5-S17. Epub 2013 Oct 16.

7.

microRNA-224 regulates Pentraxin 3, a component of the humoral arm of innate immunity, in inner ear inflammation.

Rudnicki A, Shivatzki S, Beyer LA, Takada Y, Raphael Y, Avraham KB.

Hum Mol Genet. 2014 Jun 15;23(12):3138-46. doi: 10.1093/hmg/ddu023. Epub 2014 Jan 26.

PMID:
24470395
8.

Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.

He HC, Han ZD, Dai QS, Ling XH, Fu X, Lin ZY, Deng YH, Qin GQ, Cai C, Chen JH, Jiang FN, Liu X, Zhong WD.

BMC Genomics. 2013 Nov 5;14:757. doi: 10.1186/1471-2164-14-757.

9.

miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling.

Ma D, Tao X, Gao F, Fan C, Wu D.

Oncol Lett. 2012 Sep;4(3):483-488. Epub 2012 Jun 7.

10.

Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.

Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW.

PLoS One. 2013 Apr 9;8(4):e61064. doi: 10.1371/journal.pone.0061064. Print 2013.

11.

Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer.

Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S.

Mol Cancer. 2013 Feb 14;12:13. doi: 10.1186/1476-4598-12-13.

12.

The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.

Giangreco AA, Nonn L.

J Steroid Biochem Mol Biol. 2013 Jul;136:86-93. doi: 10.1016/j.jsbmb.2013.01.001. Epub 2013 Jan 16. Review.

13.

The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.

Tu HF, Liu CJ, Chang CL, Wang PW, Kao SY, Yang CC, Yu EH, Lin SC, Chang KW.

PLoS One. 2012;7(12):e51606. doi: 10.1371/journal.pone.0051606. Epub 2012 Dec 14.

14.

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.

Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S.

Oncogene. 2013 Aug 29;32(35):4139-47. doi: 10.1038/onc.2012.424. Epub 2012 Sep 17.

15.

NF-κB-dependent microRNA-125b up-regulation promotes cell survival by targeting p38α upon ultraviolet radiation.

Tan G, Niu J, Shi Y, Ouyang H, Wu ZH.

J Biol Chem. 2012 Sep 21;287(39):33036-47. Epub 2012 Jul 31.

16.

Antagonism pattern detection between microRNA and target expression in Ewing's sarcoma.

Martignetti L, Laud-Duval K, Tirode F, Pierron G, Reynaud S, Barillot E, Delattre O, Zinovyev A.

PLoS One. 2012;7(7):e41770. doi: 10.1371/journal.pone.0041770. Epub 2012 Jul 25.

17.

Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population.

Liu J, Liu J, Wei M, He Y, Liao B, Liao G, Li H, Huang J.

DNA Cell Biol. 2012 Jul;31(7):1296-302. doi: 10.1089/dna.2011.1600. Epub 2012 Apr 16.

18.

MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs S.

Nucleic Acids Res. 2012 Apr;40(8):3689-703. doi: 10.1093/nar/gkr1222. Epub 2011 Dec 30.

19.

A miRNA expression signature that separates between normal and malignant prostate tissues.

Carlsson J, Davidsson S, Helenius G, Karlsson M, Lubovac Z, Andrén O, Olsson B, Klinga-Levan K.

Cancer Cell Int. 2011 May 27;11(1):14. doi: 10.1186/1475-2867-11-14.

20.

MicroRNA gene dosage alterations and drug response in lung cancer.

Enfield KS, Stewart GL, Pikor LA, Alvarez CE, Lam S, Lam WL, Chari R.

J Biomed Biotechnol. 2011;2011:474632. doi: 10.1155/2011/474632. Epub 2011 Mar 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk